Trident Lifeline Limited Share Price

₹ 417.00

+₹13.95 (3.46%)
1D
Last updated 03 Nov, 2026, 15:29 IST
BSE: 543616
|
Pharmaceuticals

Trident Lifeline Limited Share Price Today

As of 3 Nov 2026, Trident Lifeline Limited share price is ₹417.00. The stock opened at ₹413.95, compared to its previous close of ₹403.05. During today's trading session, Trident Lifeline Limited share price moved in the range of ₹413.95 to ₹417.00, with an average price of ₹415.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹229.95 and a high of ₹442.00.

Share price over the last 1 day rose from 414.00 to 417.00, ranging between 414.00 and 417.00.

₹413.95
3.46% up today
₹417.00
1D LOW
1D HIGH

Trident Lifeline Limited Stock Insights

Latest Earning
Op Profit TrendUp by 33.28% QoQ
Latest Earning
Net Profit TrendUp by 30.18% QoQ
Latest Earning
Revenue TrendUp by 40.13% QoQ
Stock Performance
OutperformingBeat Nifty by 61.05 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 0.12%
Shareholding Pattern
DIIDII decreased stake by 0.24%
Shareholding Pattern
FIIFII decreased stake by 0.21%
Trident Lifeline Limited stock performance
Open₹413.95
High₹417.00
Low₹413.95
Prev. close₹403.05
Trident Lifeline Limited trading activity
Volume5,400
Average traded price₹414.65
Last traded time03:29:27 03 Nov
Last traded quantity600

Circuit
L
H
₹322.45
₹483.65
52-week
L
H
₹229.95
₹442.00
Mkt Cap Cr
489.90

P/E
20.89

P/B
4.22

ROA
9.13%
ROE
19.91%

ROCE
18.07%

Quick Ratio
1.17

EV/EBITDA
13.17

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Trident Lifeline outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Trident Lifeline appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Trident Lifeline revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Trident Lifeline Limited Company Background

ISIN
INE0MKA01014
Sector Market Cap
₹ 489.90 Cr

Trident Lifeline Limited (TLL) is an India-based medication provider. The Company produces and sells finished doses. Its geographical segment includes India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World. It discovered manufacturing formulations under its own brands alongside a loan license and a contract manufacturing model. It deals in capsules, tablets, liquid ointments, gels, ice gels, mouthwash, paste, solution, suspension, toothpaste, syrup, and cream. The product portfolio of the Company comprises a wide range of drugs like Anti-Bacterial, Anti-Diarrheal, Anti-Fungal, Anti-Malarial, Anti-Diabetic, Dental Cure, Pr, Multivitamin, Multimineral Nyteraceutoton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Anti-Lipidemic Drug, Anti-Parasiticical and Non-steroidal anti-inflammatory drugs (NSAIDS).

Trident Lifeline Limited Financial Highlights

  • Revenue: Trident Lifeline Limited reported revenue of ₹138.29 crore in FY26 vs ₹95.19 crore in FY25. It showed an increase of 45.28% on a yearly basis.
  • Operating Profit: Trident Lifeline Limited reported an operating profit of ₹27.19 crore in FY26 vs ₹13.61 crore in FY25. It showed an increase of 99.78% on a year-on-year basis.
  • Net Profit: Trident Lifeline Limited reported a net profit of ₹19.32 crore in FY26 vs ₹10.49 crore in FY25. It showed an increase of 84.18% on a yearly basis.

Trident Lifeline Limited Quarterly Result Highlights

  • Trident Lifeline Limited reported revenue of ₹48.05 crore in Sep 2026, compared with ₹34.29 crore in Jun 2026, representing an increase of 40.13% on a quarter-on-quarter (QoQ) basis.
  • Trident Lifeline Limited reported an operating profit of ₹8.81 crore in Sep 2026, compared with ₹6.61 crore in Jun 2026, representing an increase of 33.28% on a quarter-on-quarter (QoQ) basis.
  • Trident Lifeline Limited reported a profit of ₹6.60 crore in Sep 2026, compared with ₹5.07 crore in Jun 2026, reflecting an increase of 30.18% on a QoQ basis.
  • The earnings per share (EPS) of Trident Lifeline Limited stood at ₹16.32 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
62.54%
FII
1.16%
Other DII
0.21%
Retail and other
36.10%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20267.24%
Jun 20265.25%
Sep 20261.16%
Oct 20261.16%

Trident Lifeline Limited Investment Returns

1 day
-1.43%

1 week
-3.33%

1 month
+7.09%

1 year
+34.35%

3 years
+109.92%

5 years
+254.95%

Trident Lifeline Limited Share Price History

Trident Lifeline Limited share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹385.10 / ₹403.05
-1.43%
30 Oct 26
₹422.60 / ₹408.90
-5.05%
29 Oct 26
₹428.85 / ₹430.65
-0.06%
28 Oct 26
₹435.50 / ₹430.90
-0.83%
Show more

Trident Lifeline Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹129.02₹86.96₹44.63₹31.69
Other Income₹10.45₹8.23₹2.08₹1.16
Total Revenue₹139.47₹95.20₹46.71₹32.85
Total Expenses₹112.28₹81.58₹38.01₹26.27
Profit Before Tax₹27.19₹13.61₹8.70₹6.58
Tax₹7.87₹3.12₹2.76₹0.56
Profit After Tax₹19.32₹10.49₹5.94₹6.02
EPS - Basic₹16.32₹10.22₹5.52₹6.22
EPS - Diluted₹16.32₹10.22₹5.52₹6.22

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹27.19₹13.61₹8.70₹6.58
Income before WC changes₹34.45₹20.47₹8.81₹6.66
Change in Assets-₹53.82-₹27.26-₹9.86-₹25.73
Change in Liabilities₹32.59₹8.70₹6.92₹1.21
Change in WC-₹21.22-₹18.56-₹2.94-₹24.52
Cash flow from Operations₹4.69-₹3.98₹2.23-₹19.00
Cash flow from Investing-₹36.61-₹13.82-₹20.36-₹9.69
Cash flow from Financing₹33.68₹13.50₹11.01₹42.28
Total Cash Flow₹1.76-₹4.31-₹7.13₹13.60
Cash (Start of the year)₹2.46₹6.65₹13.78₹0.18
Cash (End of the year)₹4.22₹2.46₹6.65₹13.78

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹97.31₹65.63₹35.10₹13.36
Current Assets₹139.51₹90.37₹51.97₹49.21
Total Assets₹236.83₹156.01₹87.08₹62.57
Current Liabilities₹87.89₹53.55₹20.26₹11.53
Net Current Asset₹51.62₹36.82₹31.72₹37.68
Non-Current Liabilities₹41.04₹32.80₹12.87₹3.93
Equity Capital₹107.89₹69.65₹53.95₹47.11
Total Equity & Liabilities₹236.83₹156.01₹87.08₹62.57

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹101.90₹67.80₹44.65₹31.69
Other Income₹4.17₹3.14₹2.20₹1.15
Total Revenue₹106.07₹70.94₹46.86₹32.85
Total Expenses₹81.09₹53.03₹37.06₹26.27
Profit Before Tax₹24.98₹17.91₹9.80₹6.57
Tax₹6.89₹4.85₹2.76₹0.56
Profit After Tax₹18.09₹13.05₹7.04₹6.01
EPS - Basic₹15.73₹11.35₹6.13₹6.22
EPS - Diluted₹15.73₹11.35₹6.13₹6.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹24.98₹17.91₹9.80₹6.57
Income before WC changes₹26.21₹18.46₹9.27₹6.66
Change in Assets-₹38.94-₹20.06-₹12.88-₹23.58
Change in Liabilities₹27.06₹7.81₹6.88₹0.89
Change in WC-₹11.88-₹12.25-₹6.00-₹22.69
Cash flow from Operations₹7.93₹1.97₹0.90-₹16.60
Cash flow from Investing-₹20.07-₹7.88-₹11.01-₹5.56
Cash flow from Financing₹14.10₹2.01₹2.35₹35.80
Total Cash Flow₹1.96-₹3.90-₹7.76₹13.64
Cash (Start of the year)₹2.11₹6.01₹13.77₹0.13
Cash (End of the year)₹4.07₹2.11₹6.01₹13.77

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹49.13₹28.65₹20.26₹8.64
Current Assets₹110.06₹69.14₹52.98₹47.86
Total Assets₹159.19₹97.79₹73.24₹56.50
Current Liabilities₹52.38₹25.14₹16.91₹10.34
Net Current Asset₹57.68₹44.00₹36.07₹37.52
Non-Current Liabilities₹7.72₹6.93₹3.65₹0.53
Equity Capital₹99.08₹65.73₹52.68₹45.63
Total Equity & Liabilities₹159.19₹97.79₹73.24₹56.50
* All values are in INR Crore
Trident Lifeline Limited market depth
Bid quantityBid priceAsk priceAsk quantity
00415600
0000
0000
0000
0000
Total bid quantity0
Total ask quantity600
Trident Lifeline Limited technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
54.27
Neutral

ATR (14)
23.51
Neutral

STOCH(9,6)
36.15
Neutral

STOCH RSI (14)
0
Bullish

ADX(9)
21.65
Bearish

UO(9)
57.09
Neutral

ROC(12)
0.2
Bullish

WillR(14)
-58.13
Neutral
Period
Simple value
Exponential vaue

5D
421.6
413.62

10D
411.62
411.6

20D
401.4
400.21

50D
350.77
362.42

100D
305.15
325.68
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Trident Lifeline Limited
Pharmaceuticals
Add Stock
Add Another

Trident Lifeline Limited Returns Calculator

Ex-date: 30 Oct 2026

Trident Lifeline Limited Share Price FAQs












Please be aware that Trident Lifeline Limited stock prices are subject to continuous fluctuations due to various factors.